Moneycontrol Be a Pro
Get App
SENSEX NIFTY
YOU ARE HERE > MONEYCONTROL > MARKETS > Pharmaceuticals > Profit & Loss account - Raymed Labs

Raymed Labs

BSE: 531207|ISIN: INE741C01017|SECTOR: Pharmaceuticals
SET ALERT
|
ADD TO PORTFOLIO
|
WATCHLIST
LIVE
BSE
Dec 13, 16:00
2.50
-0.13 (-4.94%)
VOLUME 2
Raymed Labs is not listed on NSE
Download Annual Report PDF Format 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | 2010

Profit & Loss account of Raymed Labs

------------------- in Rs. Cr. -------------------
Mar '19 Mar '18 Mar '17 Mar '16 Mar '15
12 mths 12 mths 12 mths 12 mths 12 mths
Income
Other Income -0.02 -0.02 -0.01 0.00 0.02
Total Income -0.02 -0.02 -0.01 0.00 0.02
Expenditure
Employee Cost 0.01 0.01 0.01 0.01 0.01
Miscellaneous Expenses 0.02 0.02 0.02 0.02 0.03
Total Expenses 0.03 0.03 0.03 0.03 0.04
Mar '19 Mar '18 Mar '17 Mar '16 Mar '15
12 mths 12 mths 12 mths 12 mths 12 mths
Operating Profit -0.03 -0.03 -0.03 -0.03 -0.04
PBDIT -0.05 -0.05 -0.04 -0.03 -0.02
PBDT -0.05 -0.05 -0.04 -0.03 -0.02
Depreciation 0.01 0.01 0.01 0.01 0.00
Profit Before Tax -0.06 -0.06 -0.05 -0.04 -0.02
PBT (Post Extra-ord Items) -0.06 -0.06 -0.05 -0.04 -0.02
Reported Net Profit -0.05 -0.06 -0.05 -0.04 -0.02
Total Value Addition 0.03 0.03 0.03 0.03 0.04
Per share data (annualised)
Shares in issue (lakhs) 42.74 42.74 42.74 42.74 42.74
Earning Per Share (Rs) -0.13 -0.13 -0.12 -0.09 -0.04
Book Value (Rs) -4.51 -4.39 -4.25 -4.14 -4.05
Source : Dion Global Solutions Limited

Results of Raymed Labs

  • News
  • Results
  • Estimates
  • Analysis
No news.

Results of Pharmaceuticals Sector

  • News
  • Results
  • Estimates
  • Analysis
No news.
Quick Links for raymedlabs
Explore Moneycontrol
Stocks     A | B | C | D | E | F | G | H | I | J | K | L | M | N | O | P | Q | R | S | T | U | V | W | X | Y | Z | Others
Mutual Funds     A | B | C | D | E | F | G | H | I | J | K | L | M | N | O | P | Q | R | S | T | U | V | W | X | Y | Z
Copyright © e-Eighteen.com Ltd. All rights reserved. Reproduction of news articles, photos, videos or any other content in whole or in part in any form or medium without express written permission of moneycontrol.com is prohibited.